Treasure Global Inc.

Treasure Global Inc, a pioneering e-commerce company, integrates artificial intelligence (AI) technology and commerce through its innovative Online-to-Offline (O2O) model, primarily via the ZCITY app. This app provides enticing rebates and cashback programs, boasting impressive growth with over 2,400,000 cumulative users and 2,000 merchants as of March 31, 2023.

Two other ventures enhance the company's portfolio. TAZTE is an automated solution transforming the food & beverage industry by streamlining operations and analyzing customer behavior. Foodlink Global, another wholly-owned subsidiary, manages food brand royalties and intellectual property, creating a strategic advantage for Treasure Global in the F&B sector.

Treasure Global leverages technology to broaden ZCITY's reach and offers a simplified e-payment gateway with lucrative deals and rewards. The rising e-commerce adoption and need for seamless online-to-offline experiences amplify the potential of Treasure Global's O2O model. It's a compelling blend of technological expertise and strategic vision, indicating a unique opportunity for investors.

Modular Medical, Inc.

Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

Belite Bio, Inc.

Belite Bio is a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs, such as Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD). The Company’s lead pipeline, Tinlarebant, is an oral tablet intended to reduce the accumulation of toxins in the eye that cause STGD1 (phase 3 global study ongoing) and contribute to GA (phase 3 global study ongoing). Tinlarebant is the only drug selected by NIH BluePrint program to treat Dry AMD and has been granted Fast Track Designation and Rare Pediatric Disease Designation in the U.S., and Orphan Drug Designation in both the U.S. and Europe for STGD1.

Harvard Bioscience, Inc.

Harvard Bioscience, Inc. is a global developer and manufacturer of life science solutions. Leading academic research and pharmaceutical industry customers worldwide rely on our technologies to enable fundamental advances in life science applications, including drug and therapy discovery, bio-production and pre-clinical regulatory safety pharmacology and toxicology testing.

Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceutical company is a clinical-stage pharmaceutical company focused on discovering and developing novel therapies for central nervous system, respiratory, and metabolic diseases. We are committed to developing better, safer, and more effective treatments that can have a real impact on the lives of our patients. Reviva discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.

Lightning eMotors, Inc.

Lightning eMotors (OTC: ZEVY) has been providing specialized and sustainable fleet solutions since 2009, deploying complete zero-emission-vehicle solutions for commercial fleets since 2018 – including cargo and passenger vans, ambulances, shuttle buses, Type A school buses, work trucks, city buses, and motor coaches. The Lightning eMotors team designs, engineers, customizes, and manufactures zero-emission vehicles to support the wide array of fleet customer needs with a full suite of control software, telematics, analytics, and charging solutions to simplify the buying and ownership experience and maximize uptime and energy efficiency. To learn more, visit our website at https://lightningemotors.com.

ICZOOM Group Inc.

ICZOOM Group Inc. is primarily engaged in sales of electronic component products to customers in Hong Kong and mainland China through its B2B e-commerce platform. These products are primarily used by China based small and medium-sized enterprises (“SMEs”) in the consumer electronic industry, Internet of Things (“IoT”), automotive electronics and industry control segments. By utilizing latest technologies, the Company’s platform collects, optimizes and presents product offering information from suppliers of all sizes, all transparent and available to its SME customers to compare and select. In addition to the sales of electronic component products, the Company also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance. For more information, please visit the Company’s website: http://ir.iczoomex.com/index.html.

Know Labs, Inc.

Know Labs, Inc. is a public company whose shares trade on the NYSE American Exchange under the stock symbol “KNW.” The Company’s technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The Company refers to its technology as Bio-RFID™. The Bio-RFID technology can be integrated into a variety of wearable, mobile or bench-top form factors. This patented and patent-pending technology makes it possible to effectively identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The first application of our Bio-RFID technology will be in a product marketed as a non-invasive glucose monitor. The device will provide the user with accessible and affordable real-time information on blood glucose levels. This product will require U.S. Food and Drug Administration clearance prior to its introduction to the market.

u-blox Holding AG

u-blox Holding AG (SIX:UBXN) is a global technology leader in positioning and wireless communication in automotive, industrial, and consumer markets. Their smart and reliable solutions, services and products let people, vehicles, and machines determine their precise position and communicate wirelessly over cellular and short-range networks. With a broad portfolio of chips, modules, and secure data services and connectivity, u‑blox is uniquely positioned to empower its customers to develop innovative and reliable solutions for the Internet of Things, quickly and cost‑effectively. With headquarters in Thalwil, Switzerland, the company is globally present with offices in Europe, Asia, and the USA.

Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies in the semiconductor industry roadmap.

Movano Health

Founded in 2018, Movano Health (Nasdaq: MOVE) is developing a suite of purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. Its first product in development, the Evie Ring, is the smart ring designed for women’s health. Featuring modern form factors, Movano Health's devices capture a comprehensive picture of a person's vital health information and uniquely translate the data into personalized and intelligent insights that empower consumers to live healthier and more balanced lives. Movano Health's end-to-end solutions will soon enable consumers and their healthcare professionals to utilize daily medical-grade data as a tool to proactively monitor and manage health outcomes.

Dyadic International Inc.

Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness.

CytoMed Therapeutics Limited

CytoMed Therapeutics Limited (Nasdaq: GDTC) is a pre-clinical biopharmaceutical company spun off from the Agency for Science, Technology and Research (A*STAR), Singapore’s national research and development agency, and focused on translating its proprietary technologies into cell-based immunotherapy cancer treatments. The development of these novel technologies was inspired by the clinical success of chimeric antigen receptor-modified T (CAR-T) cells in treating hematological malignancies and introduces solutions for the clinical limitations and commercial challenges inherent in extrapolating the CAR-T principle into treatments for solid tumors.

Today, CytoMed has established two novel, patented patient blood cell-independent therapies to manufacture “off-the-shelf” cell-based cancer immunotherapies: one treatment innovating the CAR-T cell approach and another generating induced pluripotent stem cells (iPSCs) and developing them into cellular therapeutics using our proprietary technologies. The former has won approval in early 2023 to commence phase 1 clinical trial in Singapore.

ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with over 700,000 ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Steatotic Liver Disease (SLD) (formerly known as NAFLD-NASH), a chronic liver spectrum that affects over two billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

Intuitive Machines, LLC.

Intuitive Machines is a diversified space company focused on space exploration. Intuitive Machines supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Intuitive Machines’ products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. For more information, please visit intuitivemachines.com.

Intchains Group Limited

Intchains Group Limited (Nasdaq: ICG) provides integrated solutions for blockchain applications that include high-performance computing ASIC chips and related software and hardware. We are currently in the process of fully transitioning toward the Web3 industry. In addition to IC-related products, there will be an increased number of infrastructure solutions implemented in the Web3 field. We aim to be a leading Web3 infrastructure provider that transforms lives and encourages Web3 industry participation.

Quantum Computing Inc.

Quantum Computing Inc. (QCi) (NASDAQ:QUBT) is bringing powerful affordable quantum hardware to the market today by creating, manipulating, and measuring the discrete properties of light, or photons. Our patented technology platform addresses applications in high-performance computing, artificial intelligence, cybersecurity, sensing, and imaging for both commercial and military markets. The use of nano-photonics provides scalable, room temperature devices that consume minimal power and are ideal for data center or cloud deployment. QCi's sustainable roadmap includes our currently-under-construction chip foundry, which promises to bring to market even more practical and powerful quantum solutions. QCi was founded in 2018 and is based in Virginia.

Calidi Biotherapeutics

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com.

Sangoma Technologies Corporation

Sangoma is a leading provider of managed cloud-based communications and technology solutions for businesses worldwide. With a deep commitment to simplifying and enhancing communications, Sangoma offers a comprehensive suite of cloud-native communication solutions, including software, endpoints, and connectivity services. With a focus on value-based offerings, Sangoma empowers businesses of all sizes to streamline their processes, reduce operational complexity, and increase efficiency. Whether it's cloud software solutions, reliable endpoints, or seamless connectivity, Sangoma's expert team is dedicated to delivering trusted and innovative services. To learn more, visit our website at www.sangoma.com.